Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance, common (in shares) at Mar. 31, 2021 [1],[2]   89,790,086            
Beginning balance at Mar. 31, 2021 [2] $ 145,112 $ 10 $ 100 $ (71) $ 373,310 $ (903) $ (227,334) $ 0
Beginning balance, preferred (in shares) at Mar. 31, 2021 [2]     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2021 [1],[2]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 14,253 [3]           14,284 [2] (31) [2]
Foreign currency translation [2] (20,781)         (20,019)   (762)
Stock-based compensation expense [2] 3,705       3,705      
Shares issued:                
Exercise of stock options (in shares) [1],[2]   178,127            
Exercise of stock options [2] 695       695      
Vesting of restricted and performance stock units (in shares) [1],[2]   207,758            
Shares for acquisition of Fyber (in shares) [1],[2]   4,716,935            
Shares for acquisition of Fyber [2] 359,233       359,233      
Acquisition of non-controlling interests in Fyber [2] 24,558             24,558
Ending balance, common (in shares) at Jun. 30, 2021 [1],[2]   94,892,906            
Ending balance at Jun. 30, 2021 [2] $ 526,775 $ 10 $ 100 $ (71) 736,943 (20,922) (213,050) 23,765
Ending balance, preferred (in shares) at Jun. 30, 2021 [2]     100,000          
Ending balance, treasury (in shares) at Jun. 30, 2021 [1],[2]       758,125        
Beginning balance, common (in shares) at Mar. 31, 2022 97,163,701 97,163,701 [2]            
Beginning balance at Mar. 31, 2022 [2] $ 516,215 $ 10 $ 100 $ (71) 745,661 (39,341) (191,788) 1,644
Beginning balance, preferred (in shares) at Mar. 31, 2022 100,000   100,000 [2]          
Beginning balance, treasury (in shares) at Mar. 31, 2022 758,125     758,125 [2]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income [2] $ 14,958           14,922 36
Foreign currency translation [2] (5,542)         (5,749)   207
Stock-based compensation expense [2] $ 6,463       6,463      
Shares issued:                
Exercise of stock options (in shares) 483,354 380,176 [2]            
Exercise of stock options [2] $ 296       296      
Vesting of restricted and performance stock units (in shares) [2]   7,763            
Shares for acquisition of Fyber (in shares) [2]   1,205,982            
Shares for acquisition of Fyber [2] 50,000       50,000      
Payment of withholding taxes related to the net share settlement of equity awards [2] $ (4,357)       (4,357)      
Ending balance, common (in shares) at Jun. 30, 2022 98,757,622 98,757,622 [2]            
Ending balance at Jun. 30, 2022 [2] $ 578,033 $ 10 $ 100 $ (71) $ 798,063 $ (45,090) $ (176,866) $ 1,887
Ending balance, preferred (in shares) at Jun. 30, 2022 100,000   100,000 [2]          
Ending balance, treasury (in shares) at Jun. 30, 2022 758,125     758,125 [2]        
[1] De minimis adjustment to previously disclosed share count; no impact on quarter-to-date or year-to-date earnings per share in any period presented.
[2] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3 in the accompanying condensed consolidated financial statements.
[3] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3 in the accompanying condensed consolidated financial statements.